Cyclin-dependent kinase pathways as targets for cancer treatment

GI Shapiro - Journal of clinical oncology, 2006 - ascopubs.org
Cyclin-dependent kinases (cdks) are critical regulators of cell cycle progression and RNA
transcription. A variety of genetic and epigenetic events cause universal overactivity of the …

Recent Progress in the Pharmacology of Imidazo [1, 2-a] pyridines

C Enguehard-Gueiffier… - Mini Reviews in Medicinal …, 2007 - ingentaconnect.com
Imidazo [1, 2-a] pyridine is a bicyclic system with a bridgehead nitrogen atom, of growing
interest in medicinal chemistry. The paper deals with the recent progress realised in the …

Discovery of a potent and selective inhibitor of cyclin-dependent kinase 4/6

PL Toogood, PJ Harvey, JT Repine… - Journal of medicinal …, 2005 - ACS Publications
A pharmacological approach to inhibition of cyclin-dependent kinases 4 and 6 (Cdk4/6)
using highly selective small molecule inhibitors has the potential to provide novel cancer …

Cyclin-dependent kinase-2 as a target for cancer therapy: progress in the development of CDK2 inhibitors as anti-cancer agents

TA Chohan, H Qian, Y Pan… - Current medicinal …, 2015 - ingentaconnect.com
Cyclin-dependent kinase-2 (CDK2) is a member of protein kinase family. It plays an
important role in regulating various events of eukaryotic cell division cycle. Accumulated …

The Lab Oddity Prevails: Discovery of Pan‐CDK Inhibitor (R)‐S‐Cyclopropyl‐S‐(4‐{[4‐{[(1R,2R)‐2‐hydroxy‐1‐methylpropyl]oxy}‐5‐(trifluoromethyl)pyrimidin‐2‐yl …

U Lücking, R Jautelat, M Krüger, T Brumby… - …, 2013 - Wiley Online Library
Lead optimization of a high‐throughput screening hit led to the rapid identification of
aminopyrimidine ZK 304709, a multitargeted CDK and VEGF‐R inhibitor that displayed a …

Pyrido[2,3-d]pyrimidin-7-ones as Specific Inhibitors of Cyclin-Dependent Kinase 4

SN VanderWel, PJ Harvey, DJ McNamara… - Journal of medicinal …, 2005 - ACS Publications
Inhibition of the cell cycle kinase, cyclin-dependent kinase-4 (Cdk4), is expected to provide
an effective method for the treatment of proliferative diseases such as cancer. The pyrido [2 …

Recent progress in CDK4/6 inhibitors and PROTACs

H Wang, J Ba, Y Kang, Z Gong, T Liang, Y Zhang, J Qi… - Molecules, 2023 - mdpi.com
Cell division in eukaryotes is a highly regulated process that is critical to the life of a cell.
Dysregulated cell proliferation, often driven by anomalies in cell Cyclin-dependent kinase …

Structural basis of inhibitor specificity of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM-1) kinase

AN Bullock, JÉ Debreczeni, OY Fedorov… - Journal of medicinal …, 2005 - ACS Publications
The kinase PIM-1 plays a pivotal role in cytokine signaling and is implicated in the
development of a number of tumors. The three-dimensional structure of PIM-1 is …

Imidazopyridine-based kinase inhibitors as potential anticancer agents: A review

F Peytam, Z Emamgholipour, A Mousavi, M Moradi… - Bioorganic …, 2023 - Elsevier
Considering the fundamental role of protein kinases in the mechanism of protein
phosphorylation in critical cellular processes, their dysregulation, especially in cancers, has …

Imidazo [1, 2-a] pyridines: Promising drug candidate for antitumor therapy

R Goel, V Luxami, K Paul - Current Topics in Medicinal …, 2016 - ingentaconnect.com
Imidazo [1, 2-a] pyridine has been shown to be an important biologically active moiety. This
review is a compilation of the scattered output of results of the anticancer activities of the …